Patents by Inventor Franciszek Kasprzykowski

Franciszek Kasprzykowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9169289
    Abstract: Compounds of formula R1-A-NH—CH(R2)—CO—R3 are presented. The compounds can be used to treat or alleviate conditions associated with bone loss or low bone density, or to inhibit osteoclast differentiation and stimulation, bone resorption and/or loosening of a prosthetic device. The compounds can be administered as a pharmaceutical composition or in a prosthetic device.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: October 27, 2015
    Assignee: STRONGBONE AB
    Inventors: Anders Grubb, Franciszek Kasprzykowski, Ulf Lerner, Beata Zolnowska, Regina Kasprzykowska
  • Publication number: 20140243274
    Abstract: Compounds of formula R1-A-NH—CH(R2)—CO—R3 are presented. The compounds can be used to treat or alleviate conditions associated with bone loss or low bone density, or to inhibit osteoclast differentiation and stimulation, bone resorption and/or loosening of a prosthetic device. The compounds can be administered as a pharmaceutical composition or in a prosthetic device.
    Type: Application
    Filed: April 21, 2014
    Publication date: August 28, 2014
    Applicant: Strongbone AB
    Inventors: Anders GRUBB, Franciszek KASPRZYKOWSKI, Ulf LERNER, Beata ZOLNOWSKA, Regina KASPRZYKOWSKA
  • Patent number: 8748370
    Abstract: Novel compounds which may be for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation, bone resorption, or loosening of a prosthetic device.
    Type: Grant
    Filed: June 17, 2010
    Date of Patent: June 10, 2014
    Assignee: Strongbone AB
    Inventors: Anders Grubb, Franciszek Kasprzykowski, Ulf Lerner, Beata Zolnowska, Regina Kasprzykowska
  • Publication number: 20120108515
    Abstract: Novel compounds which may be for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation, bone resorption, or loosening of a prosthetic device.
    Type: Application
    Filed: June 17, 2010
    Publication date: May 3, 2012
    Applicant: NEOBIOTICS AB
    Inventors: Anders Grubb, Franciszek Kasprzykowski, Ulf Lerner, Beata Zolnowska, Regina Kasprzykowska
  • Patent number: 8097582
    Abstract: A compound having the general formula (I) R1—NH—CH[(CH2)n—NH—C(NH)—NH2]-CO—R2-A-R4; a pharmaceutical composition comprising the compound and use of the compound for the manufacturing of a medicament for the treatment of a disease such as a microbial disease and/or proliferation/stimulation of eukaryotic cells is described.
    Type: Grant
    Filed: May 4, 2007
    Date of Patent: January 17, 2012
    Assignee: Neobiotics AB
    Inventors: Anders Grubb, Aftab Jasir, Claes Schalén, Franciszek Kasprzykowski, Regina Kasprzykowska
  • Publication number: 20100247648
    Abstract: The invention relates to compositions comprising a compound based on the general formula (I) R1-Arg-R2—NH—CH(R3)—CH2—NH—R4??(I) The composition may be used to eliminate and/or reduce microorganisms such as bacteria, viruses, fungi and protozoa.
    Type: Application
    Filed: March 8, 2010
    Publication date: September 30, 2010
    Applicant: Neobiotics AB
    Inventors: Anders Grubb, Aftab Jasir, Claes Schalén, Franciszek Kasprzykowski, Regina Kasprzykowska
  • Patent number: 7691805
    Abstract: The invention relates to compositions comprising a compound based on the general formula (I) R1-Arg-R2—NH—CH(R3)—CH2—NH—R4 ??(I) and a carrier, diluent or an excipient.
    Type: Grant
    Filed: November 10, 2005
    Date of Patent: April 6, 2010
    Assignee: Neobiotics AB
    Inventors: Anders Grubb, Aftab Jasir, Claes Schalén, Franciszek Kasprzykowski, Regina Kasprzykowska
  • Publication number: 20090118198
    Abstract: The invention relates to a compound having the general formula (I) R1—NH—CH[(CH2)n—NH—C(NH)—NH2]-CO—R2-A-R4; a pharmaceutical composition comprising said compound and use of said compound for the manufacturing of a medicament for the treatment of a disease such as a microbial disease and/or proliferation/stimulation of eukaryotic cells.
    Type: Application
    Filed: May 4, 2007
    Publication date: May 7, 2009
    Inventors: Anders Grubb, Aftab Jasir, Claes Schalen, Franciszek Kasprzykowski, Regina Kasprzykowska
  • Publication number: 20080255055
    Abstract: The invention relates to compositions comprising a compound based on the general formula (I) R1-Arg-R2—NH—CH(R3)—CH2—NH—R4 (I) The composition may be used to eliminate and/or reduce microorganisms such as bacteria, viruses, fungi and protozoa.
    Type: Application
    Filed: November 10, 2005
    Publication date: October 16, 2008
    Applicant: NEOBIOTICS AB
    Inventors: Anders Grubb, Aftab Jasir, Claes Schalen, Franciszek Kasprzykowski, Regina Kasprzykowska
  • Publication number: 20060116327
    Abstract: The invention relates to compositions comprising a compound based on the general formula (I) R1-Arg-R2—NH—CH(R3)—CH2—NH—R4 ??(I) The composition may be used to eliminate and/or reduce microorganisms such as bacteria, viruses, fungi and protozoa.
    Type: Application
    Filed: November 10, 2005
    Publication date: June 1, 2006
    Applicant: Neobiotics AB
    Inventors: Anders Grubb, Aftab Jasir, Claes Schalen, Franciszek Kasprzykowski, Regina Kasprzykowska